US 7097965
Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein
granted A61KA61K39/00
Quick answer
US patent 7097965 (Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Aug 29 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K39/00